
Leqembi Likes Asia’s Genes. Why?
New evidence suggests genetics—not geography—may explain why Leqembi causes fewer ARIA brain side effects in parts of Asia, and what that means for families everywhere.

New evidence suggests genetics—not geography—may explain why Leqembi causes fewer ARIA brain side effects in parts of Asia, and what that means for families everywhere.

Alzheimer’s treatment eligibility may be far larger than previously thought. A major Nature study using blood tests suggests millions more older adults could qualify for treatment than current use reflects. As diagnosis becomes easier, demand for drugs like Leqembi could shift sharply.

New studies highlight smoother tolerability, easier routines, and practical safety updates that make the rivastigmine patch an increasingly caregiver-friendly option.

Three major GLP-1 trials came out in late 2025. One weight-loss drug slowed early Alzheimer’s decline, while two others failed. Surprisingly, this mixed pattern may point the way toward a promising new treatment direction.

New long-term data suggests lecanemab could delay the shift from mild memory loss to moderate Alzheimer’s by up to eight years—offering families precious time and renewed hope.

Leqembi is one of the first Alzheimer’s treatments proven to slow decline. A new MRI study helps explain what it can—and cannot—do in the brain’s early months, offering clearer expectations for caregivers.

NEW RESEARCH: A diabetes medication already helping millions, called Jardiance, improves memory, strengthens blood flow, and supports overall brain health in pre- and early Alzheimer’s.

IMAGINE THIS: Instead of going to an infusion center for treatment, you can switch to a weekly injection at home. That’s now a reality for many Alzheimer’s patients.

PRODUCT OF THE WEEK: Caregivers love this pill box, as do patients and professionals. Simply fill it once a month. Roomy, simple, ingenious.

Caring for someone with Alzheimer’s is demanding enough. Now, instead of traveling for hours of infusions, families can turn to Leqembi IQLIK—a once-weekly injection approved by the FDA that makes treatment simpler, safer, and closer to home.

POLICE DASH CAM VIDEO + ARTICLE:
See a man with Alzheimer’s driving 60 MPH (100kph) at police, against traffic, on New Year’s. Learn how-and-when to help a person with Alzheimer’s hand in the car keys.

VIDEO+ARTICLE CARE TIP: Midnight snacks are great on New Year’s Eve and even greater on midnight dementia-care shifts. Learn how late-night munchies solved a nurse’s wandering & behavior problems.

Being deeply loved by someone gives you strength, while loving someone deeply gives you courage. (Lao Tzu)

It is one of the most beautiful Compensations of this life thatNo man can sincerely try to help anotherWithout helping himself.

What are the early symptoms of Alzheimer’s? When to get a professional evaluation.

SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.

Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
No spam, only news and updates.


